ThreeD Capital Amends $1.2 Million Unsecured Loan to CEO

Reuters07:35
ThreeD Capital Amends $1.2 Million Unsecured Loan to CEO

ThreeD Capital Inc., a Canadian-based venture capital firm, has announced an amended loan agreement with its Chief Executive Officer, Sheldon Inwentash. Under the amended terms, ThreeD Capital is providing a loan to Mr. Inwentash in the principal amount of $1,215,769. The loan bears interest at a rate of 5% per annum, is unsecured, and is due on December 31, 2026. As this transaction involves a related party, it falls under Multilateral Instrument 61-101, but the company is exempt from certain valuation and minority approval requirements since the loan amount does not exceed 25% of its market capitalization. The transaction remains subject to approval by the Canadian Securities Exchange.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ThreeD Capital Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9616302) on December 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment